Apellis Pharmaceuticals · 1 month ago
Associate Director, R&D Finance – Technical Operations
Waltham, Massachusetts, United States
Full-time
Hybrid
Lead/Staff, Director/Executive
$163K/yr - $244K/yr
10+ years expApellis is a high-growth, innovative biopharmaceutical company pioneering targeted C3 therapies to address debilitating diseases. The Associate Director of R&D Finance will serve as the strategic financial partner to the Technical Operations organization, driving financial planning, reporting, and strategic insights to enable informed decision-making and optimal resource allocation.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Serve as a trusted Finance Business Partner to the Tech Ops Executive/Senior Leadership, delivering strategic and operational guidance to support critical decision-making, drive organizational priorities, and ensure financial alignment with long-term objectives
Foster strong relationships with senior stakeholders to proactively identify opportunities, address challenges, and enable optimal resource allocation across Technical Operations
Lead development and coordination of annual budgets, interim forecasts, and long-range financial plans for Tech Ops
Deliver proactive financial analysis and timely reporting to track performance against budget and forecast, enabling data-driven decisions
Oversee month-end and quarter-end close processes, including accruals, ensuring compliance with GAAP, SOX, and Apellis accounting policies
Collaborate with Tech Ops leadership to understand complexities of clinical and commercial supply and their impact on development plans and demand forecasts
Ensure accuracy of financial exposure related to external contract manufacturers
Partner with cost accounting to ensure proper P&L classification (COGS vs. expense) and guide budget/forecast accuracy
Provide analytical support for pipeline advancement, lifecycle management, and upcoming launches (e.g., C3G/IC-MPGN)
Drive process improvements and implement scalable financial practices to support Apellis’ growth trajectory
Qualification
Required
Bachelor's degree in Accounting, Finance, or related field; MBA or CPA preferred
10+ years of progressive experience in accounting and financial planning/analysis
3+ years of finance experience supporting Technical Operations in a publicly traded biopharma company
Strong knowledge of US GAAP and SOX compliance for public companies
Exceptional communication, presentation, and stakeholder management skills; ability to influence across all levels
Proven ability to work collaboratively with non-finance teams while representing Finance effectively
Comfortable challenging the status quo, driving change, and thriving in a fast-paced, dynamic environment
Strong analytical skills with ability to manage large datasets and deliver under tight deadlines
Preferred
MBA or CPA preferred
Experience with SAP (ERP) and Adaptive Insights (planning/reporting) strongly preferred
Benefits
401(k) plan with company match
Inclusive family building benefits
Flexible time off
Summer and winter shutdowns
Paid family leave
Disability and life insurance
Company
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
501-1000 employees
H1B Sponsorship
Apellis Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (6)
2023 (6)
2022 (8)
2021 (7)
2020 (3)
Funding
Current Stage
Public CompanyTotal Funding
$919.6MKey Investors
Swedish Orphan BiovitrumSixth StreetNorthern Star Partners
2025-06-01Post Ipo Debt· $275M
2024-05-14Post Ipo Debt· $475M
2022-04-14Post Ipo Equity· $1.07M
Leadership Team
Cedric Francois
Co-founder, Chief Executive Officer , and President
Caroline Baumal
Chief Medical Officer
Recent News
News Powered by Cision
2025-12-05
Company data provided by crunchbase